Edward Turos
28Patents
4h-index
26Co-inventors
63Inventor score
Filing activity: Jul 24, 2000 → Sep 13, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6946458B2 | N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus | Human Necessities | 27 | Expired |
| US9149440B2 | Nanoparticles for drug-delivery | Human Necessities | 21 | Active |
| US6476015B1 | N-thiolated &bgr;-lactam antibiotics | Chemistry; Metallurgy | 14 | Expired |
| US7026472B2 | Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof | Chemistry; Metallurgy | 5 | Expired |
| US8414926B1 | Nanoparticles with covalently bound surfactant for drug delivery | Performing Operations; Transporting | 3 | Active |
| US8093027B2 | Method for producing biocomposite comprising collagen and polymer | Human Necessities | 3 | Active |
| US7332611B2 | N-thiolated 2 oxazolidone antibiotics | Chemistry; Metallurgy | 2 | Expired |
| US7635693B2 | Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof | Chemistry; Metallurgy | 2 | Active |
| US8470958B1 | Antibiotic-bound poly(caprolactone) polymer | Emerging Cross-Sectional Technologies | 1 | Active |
| US7482467B2 | N-thiolated 2-oxazolidinone-derived antibiotics | Chemistry; Metallurgy | 1 | Active |
| US11857679B2 | Nanoparticles carrying antibiotics | Emerging Cross-Sectional Technologies | 0 | Active |
| US8143398B1 | Activity of new N-acylated ciprofloxacin derivatives against faculative intracellular bacteria | Chemistry; Metallurgy | 0 | Active |
| US9533051B2 | Menthol-based nanoparticles for drug delivery | Human Necessities | 0 | Active |
| US9512160B2 | Antibacterial S-heterosubstituted disulfides | Chemistry; Metallurgy | 0 | Active |
| US10080725B2 | Antibacterial S-heterosubstituted disulfides | Chemistry; Metallurgy | 0 | Active |
| US9949480B2 | N-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US9670179B1 | Antibiotic compositions and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US8722937B2 | Asymmetric disulfides and aryl-alkyl disulfides as anti-bacterial agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US10588860B2 | Poly(vinyl benzoate) nanoparticles for molecular delivery | Human Necessities | 0 | Active |
| US8703963B2 | Derivative N-thiolated 2-oxazolidinone antibiotics | Chemistry; Metallurgy | 0 | Active |
| US8110678B2 | Antibiotic-bound poly(caprolactone) polymer | Emerging Cross-Sectional Technologies | 0 | Active |
| US8404671B2 | Heterosubstituted N-thiolated beta-lactam compounds and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10350177B2 | Antibacterial S-heterosubstituted disulfides | Chemistry; Metallurgy | 0 | Active |
| US7846920B2 | Heterosubstituted N-thiolated beta-lactam compounds and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11116725B2 | Nanoparticles carrying antibiotics | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.